Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

Item
http://www.wikidata.org/entity/Q36891717
Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.Cognitive decline in Parkinson disease.Epidermal growth factor prevents oligomeric amyloid-β induced angiogenesis deficits in vitro.Correlation of Plasma EGF with Striatal Dopamine Transporter Availability in Healthy Subjects.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Unlocking the mystery of biomarkers: A brief introduction, challenges and opportunities in Parkinson Disease.
P2860

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease

Item
http://www.wikidata.org/entity/Q36891717
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
@en
type
label
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
@en
prefLabel
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932